Trial intelligence / Profile preview

Baoji oral liquid for functional dyspepsia in children (real-world study)

ChiCTR2300069106Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Henan University of Chinese Medicine
Start
Dec 2022
Countries
1
01

Overview

Phase 4, open-label trial of Baoji in functional dyspepsia (FD) (3 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Composite effective rate of functional dyspepsia symptoms (FD症状综合有效率), Disappearance rate of individual functional dyspepsia symptoms (单项FD症状消失率) and 1 more. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

Baoji
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on ChiCTR2300069106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300069106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call